Yuan Jing, Chen Minghao, Xu Qingyun, Liang Jianxin, Chen Ruixue, Xiao Ya, Fang Meixia, Chen Liguo
School of Chinese Medicine, Jinan University, Guangzhou, China.
Reproductive Center, Guangdong Women and Children Hospital, Guangzhou, China.
Cell Physiol Biochem. 2017;43(1):120-135. doi: 10.1159/000480330. Epub 2017 Aug 28.
BACKGROUND/AIMS: This study aimed to screen microRNAs and their corresponding target genes that are associated with vascular injury in type two diabetes mellitus (T2DM), investigate the effects of differentially expressed miRNAs and their target genes on high glucose-induced vascular injury and establish the mechanism underlying these effects.
A high-throughput digital gene expression (DGE) sequencing was performed to sequence microRNAs (miRNAs) and messenger RNAs (mRNAs) and determine their differential expression in human umbilical vein endothelial cells (HUVECs) incubated with serum samples from patients with T2DM and healthy volunteers. The HUVECs were transfected with si-TNF-α (tumor necrosis factor α) and a miR-149-5p inhibitor or mimic in vitro and then treated with normal or high glucose. The relative content of nitric oxide (NO) in the cells was detected using the Griess Reagent System. The mRNA and protein expression of endothelial nitric oxide synthase (eNOS) were determined by qRT-PCR and Western blotting. The content of endothelin-1 (ET-1), von Willebrand factor (vWF), and intercellular adhesion molecular-1 (ICAM-1) were detected using an enzyme-linked immunosorbent assay (ELISA) kit. Apoptosis was determined by flow cytometry using the Annexin V/PI apoptosis detection kit. The mRNA and protein expression levels of ER stress (ERS) markers were determined by qRT-PCR and Western blotting.
Based on the high-energy sequencing and in vitro pre-experiment studies, we determined that miR-149-5p and TNF-α were a differentially expressed mRNA/miRNA pair in T2DM with vascular injury. The luciferase reporter assay results demonstrated that miR-149-5p could directly target TNF-α. The upregulation of miR-149-5p reduced the high glucose-induced dysfunction in the HUVECs by significantly decreasing the levels of ET-1, vWF, and ICAM-1 and increasing the level of NO and the expression of eNOS. Additionally, we found that miR-149-5p can improve cell injury and reduce apoptosis by restoring the ameliorated high glucose-induced expression of ERS markers.
TNF-α and miR-149-5p were differentially expressed in T2DM vascular endothelial injury. The over-expression of miR-149-5p ameliorates the high glucose-induced injury in the HUVECs by regulating the expression of TNF-α and ERS markers.
背景/目的:本研究旨在筛选与2型糖尿病(T2DM)血管损伤相关的微小RNA(miRNA)及其相应的靶基因,研究差异表达的miRNA及其靶基因对高糖诱导的血管损伤的影响,并阐明其作用机制。
进行高通量数字基因表达(DGE)测序,对miRNA和信使核糖核酸(mRNA)进行测序,并确定它们在与T2DM患者和健康志愿者血清样本孵育的人脐静脉内皮细胞(HUVEC)中的差异表达。体外将HUVEC转染小干扰肿瘤坏死因子α(si-TNF-α)、miR-149-5p抑制剂或模拟物,然后用正常或高糖处理。使用格里斯试剂系统检测细胞中一氧化氮(NO)的相对含量。通过实时定量聚合酶链反应(qRT-PCR)和蛋白质免疫印迹法检测内皮型一氧化氮合酶(eNOS)的mRNA和蛋白质表达。使用酶联免疫吸附测定(ELISA)试剂盒检测内皮素-1(ET-1)、血管性血友病因子(vWF)和细胞间黏附分子-1(ICAM-1)的含量。使用膜联蛋白V/碘化丙啶(Annexin V/PI)凋亡检测试剂盒通过流式细胞术检测细胞凋亡。通过qRT-PCR和蛋白质免疫印迹法检测内质网应激(ERS)标志物的mRNA和蛋白质表达水平。
基于高通量测序和体外预实验研究,我们确定miR-149-5p和TNF-α是T2DM血管损伤中差异表达的mRNA/miRNA对。荧光素酶报告基因检测结果表明,miR-149-5p可直接靶向TNF-α。miR-149-5p的上调通过显著降低ET-1、vWF和ICAM-1水平,增加NO水平和eNOS表达,减轻了高糖诱导的HUVEC功能障碍。此外,我们发现miR-149-5p可以通过恢复高糖诱导的ERS标志物表达改善来改善细胞损伤并减少细胞凋亡。
TNF-α和miR-149-5p在T2DM血管内皮损伤中差异表达。miR-149-5p的过表达通过调节TNF-α和ERS标志物的表达减轻高糖诱导的HUVEC损伤。